Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogenon versus Premarin vaginal cream non-inferiority study in postmenopausal women
ACTRN12610000103066Phase 3Not yet recruiting
- Sponsor
- Lek
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of conjugated estrogens in vaginal atrophy and Hypoestrogenemia (2 arms), sponsored by Lek. Primary endpoint: Endometrium thickness. Planned start Mar 2010; status: not yet recruiting.
02
Drugs
conjugated estrogens
03
Conditions
vaginal atrophyHypoestrogenemia
Beyond the preview
Go deeper on ACTRN12610000103066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000103066.